VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 57 filers reported holding VINCERX PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,166 | -50.3% | 37,054 | -37.2% | 0.00% | – |
| Q2 2023 | $76,747 | +86132.6% | 59,036 | -30.7% | 0.00% | – |
| Q1 2023 | $89 | +25.4% | 85,175 | +21.5% | 0.00% | – |
| Q4 2022 | $71 | -100.0% | 70,076 | -66.2% | 0.00% | – |
| Q3 2022 | $287,000 | -29.1% | 207,612 | -32.3% | 0.00% | – |
| Q2 2022 | $405,000 | +118.9% | 306,598 | +562.4% | 0.00% | – |
| Q1 2022 | $185,000 | -66.1% | 46,288 | -13.4% | 0.00% | – |
| Q4 2021 | $545,000 | -17.8% | 53,437 | +4.7% | 0.00% | – |
| Q2 2021 | $663,000 | -56.0% | 51,043 | -34.7% | 0.00% | -100.0% |
| Q1 2021 | $1,508,000 | – | 78,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $6,473,000 | 1.96% |
| Affinity Asset Advisors, LLC | 1,374,098 | $5,496,000 | 0.88% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $4,123,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 720,161 | $2,881,000 | 0.41% |
| Rubric Capital Management LP | 2,107,000 | $8,428,000 | 0.30% |
| Long Focus Capital Management, LLC | 430,200 | $1,721,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 327,236 | $1,309,000 | 0.20% |
| Clearline Capital LP | 412,657 | $1,651,000 | 0.19% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $1,540,000 | 0.16% |
| Sio Capital Management, LLC | 102,049 | $408,000 | 0.14% |